Position in VERA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$9,706,050
-$2,511,558 QoQ
Shares Held
241,264
0.0% QoQ
Ownership
0.336%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Alphabet Inc. holds $506,403,978 across 13 Biotechnology names. VERA ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
3,292,525 | $320,198,056 | |
| 2 | PRME |
Prime Medicine, Inc.
|
16,562,498 | $57,637,493 | |
| 3 | MAZE |
Maze Therapeutics, Inc.
|
1,388,583 | $41,449,202 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,823,126 | $25,266,977 | |
| 5 | RLAY |
Relay Therapeutics, Inc.
|
1,564,173 | $15,563,521 | |
| 6 | GLUE |
Monte Rosa Therapeutics, Inc.
|
684,275 | $11,256,323 | |
| 7 | VERA |
Vera Therapeutics, Inc.
This page
|
241,264 | $9,706,050 | |
| 8 | SANA |
Sana Biotechnology, Inc.
|
2,812,500 | $8,100,000 |
All Filings in VERA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,706,050 | 241,264 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $12,217,608 | 241,264 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,011,131 | 241,264 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $5,684,179 | 241,264 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $5,795,161 | 241,264 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $10,203,054 | 241,264 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $10,663,868 | 241,264 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $8,728,931 | 241,264 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $10,403,303 | 241,264 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $4,638,300 | 301,580 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $4,134,661 | 301,580 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,840,359 | 301,580 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $2,340,260 | 301,580 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,835,573 | 301,580 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,426,669 | 301,580 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $4,104,503 | 301,580 | Shares | Defined | 2022-11-15 | |
| 2022-03-31 | $7,084,114 | 301,580 | Shares | Defined | 2022-11-15 | |
| 2021-12-31 | $19,068,941 | 713,658 | Shares | Defined | 2022-11-15 | |
| 2021-09-30 | $16,392,123 | 944,791 | Shares | Defined | 2022-11-15 | |
| 2021-06-30 | $12,527,928 | 944,791 | Shares | Defined | 2022-11-15 | |
| No filing history on record for this holder in this stock. | ||||||